ʻO ARA-290 kahi peptide synthetic i haku ʻia 11 nā ʻakika amino, loaʻa mai kahi ʻano hoʻohālike ʻekolu-dimensional o ka hormone endogenous erythropoietin (EPO). Hoʻohālike ia i ka pilina paʻa o ka erythropoietin receptor β-co-receptor (βcR), koho koho i ka hoʻoponopono ʻana i ka protein receptor. ʻOi aku ka mea nui, ʻO kēia ʻano hana e hoʻopuni ana i nā pōʻino proliferative e pili pū ana me nā mea loaʻa EPO kuʻuna.
Ua hōʻike mua ʻia ma 2008, ʻO ka puka ʻana mai o ARA-290 e hōʻike ana i kahi hoʻololi hoʻolālā i ka noiʻi EPO mai ka hematopoietic therapy i ka hoʻoponopono ʻana i ka ʻiʻo immunomodulation.
Me ka mīkini, ma ka hoʻopaʻa ʻana me ka pili kiʻekiʻe i ka IRR, Ho'ā 'o ARA-290 i nā ala hōʻailona o lalo, komo JAK2-STAT3 a PI3K-Kanawai, e hoʻololi hope loa i nā mea hopena koʻikoʻi e like me NF-κB.
Ma waho aʻe o kēia, Hōʻike ka ARA-290 i nā hopena anti-inflammatory a me immunomodulatory, hoʻoikaika i ka hoʻoponopono neural a hoʻēmi i ka ʻeha neuropathic, hoʻoponopono i ka metabolism, a hōʻike i ka hiki therapeutic no ka mālama ʻana i ka liʻiliʻi fiber neuropathy, ʻO ka maʻi Charcot-Marie-Tooth, a me ka neuropathy diabetic.
Kaʻina
H-Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH
Helu CAS
1208243-50-8
ʻĀpana Molekala
C51H84N16O21
Kaumaha Molekala
1257.3
Noiʻi o ARA-290
1.Hoʻonui i ka Angiogenic Potential a Homing Capacity o Kaʻapuni ʻana i nā Pūnaehana Progenitor Endothelial:
- ʻO ka mua, ʻO nā maʻi ischemic e hōʻike ana i nā maʻi vascular pōʻino. Me ka nui o ka momona a me ka maʻi diabetes, ke piʻi mau nei ka nui o nā maʻi i hoʻopilikia ʻia. No laila, no ka poʻe me ka maʻi vascular koʻikoʻi, ʻO ka ʻoki ʻana i kahi koho lapaʻau mua.
- Ma kahi haʻawina pili, Hāʻawi ʻia ʻo ARA-290 i nā ʻiole me ischemia lālā mau (CLI). Ua hōʻike ʻia nā hopena e hoʻomaikaʻi nui ʻo ARA-290 i ka hoʻonui / neʻe ʻana a pale aku i ka apoptosis i hoʻokomo ʻia i ka hydrogen peroxide..
- Eia hou, hoʻokahi injection o ARA-290 i hoʻomaikaʻi i ke kahe koko o nā lālā a me ka nui o ka capillary.
Hui pū, Hōʻike kēia mau ʻike i ka hoʻohana ʻana i ka ARA-290 ma ke ʻano he adjuvant hiki ke hoʻonui i nā waiwai angiogenic intrinsic o Endothelial colony forming cell(ECFC) a me kā lākou hoʻi ʻana i vivo i nā pūnaewele ischemic, ma laila e hoʻoulu ai i ka angiogenesis. Pela, Hāʻawi kēia i kahi ala lapaʻau hou no nā maʻi ischemic mau loa.
2.Hoʻomaikaʻi i ka hoʻokuʻu ʻana o ka insulin a me ka hoʻomanawanui ʻana o ka glucose ma ke ʻano 2 Nā maʻi maʻi diabetes:
I ka pae metabolic, Hoʻonui nui ʻo ARA-290 i ka ʻae ʻana i ka glucose i nā ʻiole maʻi maʻi me ka ʻole e pili ana i nā ʻiole maʻi maʻi ʻole.. Kūkākūkā, hoʻoulu ʻia i ke kiʻekiʻe GSIS(ʻO ka hoʻoulu ʻana o ka insulin i ka glucose) pae, ka hopena e hoʻomaikaʻi i ka glucose oxidation a ʻO Adenosine triphosphate(ATP) hana ʻana. Ma o keia hana, ma ka hooikaika ana ATP-sensitive potassium channel(CAT) pani ʻana i ke kahawai, ʻo ia ka hopena i ka huna ʻana o ka insulin.
3.Nā hopena anti-inflammatory a me nā neuroprotective:
E loiloi i ka neuroinflammation, i loko o kahi hoʻokolohua lapaʻau e pili ana i nā ʻiole Lewis me hoʻokolohua autoimmune encephalomyelitis (EAE), ʻO ka hoʻomau mau ʻana o nā injections ARA-290 i hōʻemi nui i ka paʻakikī o ka EAE i nā ʻiole. I ke ʻano wae, ua hōʻemi kēia lapaʻau i ka hōʻiliʻili ʻana o nā cell inflammatory i ka spinal cord EAE a hoʻopaʻa i ka hoʻonui a me ka hōʻike ʻana o nā cytokines e like me interleukin., kumu necrosis kumu-α, a hiki ʻole nitric oxide synthase ma ke kuamoʻo ʻiole EAE.
Eia kekahi, Ua hōʻike ʻia nā haʻawina in vitro i ka ARA-290 inhibits Kelepona Th1 a me Th7 polarization ma EAE lymphocytes. Hui pu, Ke hōʻike nei kēia hoʻokolohua he waiwai lapaʻau ko ka ARA-290 no ka sclerosis lehulehu.
4.Hoʻoikaika i ka hoʻoponopono ʻana i ka neural a me ka hoʻēmi ʻana i ka ʻeha Neuropathic:
ʻIke ʻia, Hiki iā ARA-290 ke hele pololei i ka pale koko-lolo, hiki iā ia ke hana pololei ganglia aʻa hope a microglia. Ma laila, hoʻopaʻa ia i nā hoʻokuʻu ʻino ʻole i loko o ka lolo o ka lolo, hoemi ana ʻike kikowaena, a hoʻololi ikaika i nā mea neurotrophic i ka wā e hoʻemi ana i ka mumū i loko o ka ganglia aʻa dorsal e hoʻoponopono i ka ʻōnaehana nerve waena..
5.Hoʻonui i ka hoʻoponopono ʻana a me ka hiki ke hana hou:
ʻO ka hope loa, Hana ʻo ARA-290 i nā cell immune innate e hōʻike ana i ka IRR, ka mea e paipai ikaika ana i ko lakou polarization mai ka pro-inflammatory M1 phenotype i ka anti-inflammatory a me ka pro-repair M2 phenotype. Ma ka hopena, hoʻopau ia i nā pane inflammatory excessive i ka hoʻoulu ʻana i ka huna ʻana o nā kumu ulu nui, ka hoʻomaʻemaʻe ʻana i nā cell apoptotic, a me ka hana ʻana i nā aʻa koko hou. ʻO ka hope loa, hoʻomaikaʻi kēia i ka paʻa o ke kūkulu ʻana a me nā waiwai mechanical o nā ʻiʻo i hoʻoponopono ʻia.
COA
HPLC
MS





